AI-generated summary
This review describes seasonal affective disorder, a mood condition that typically appears in autumn and winter and remits in spring or summer. The authors report that about 5 percent of the U.S. population experiences it in a given year, and that light therapy, antidepressants and cognitive behavior therapy are all appropriate options with comparable effectiveness. They suggest first-line choice should be guided by patient preference.
- Who or what was studied
- Patients with seasonal affective disorder; the abstract cites prevalence in the U.S. population
- Limits stated in the abstract
- The abstract does not state the number or design of included studies, so the evidence base behind the comparative-effectiveness claim is unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.